Metraipolis › archive › dc_48bddea7f874

Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin — Europe PMC PMID:41614077

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41614077
DOI
10.3389/fphar.2025.1727729
License (as archived)
solo-consultazione
Archived
2026-11-06T19:46:41.051Z
SHA-256 of the archived text
9db47529fb468615e31258cacb96079d0a4638cd647ea88db90bd6a0cea1f626
Stable URL of this page
https://metraipolis.com/documento/dc_48bddea7f874

How to cite

Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin — Europe PMC PMID:41614077 — Europe PMC (en), https://europepmc.org/article/MED/41614077 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48bddea7f874 (Metraipolis archive dc_48bddea7f874, sha256 9db47529fb468615e31258cacb96079d0a4638cd647ea88db90bd6a0cea1f626)
BibTeX
@misc{dc48bddea7f874,
  title = {Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin — Europe PMC PMID:41614077},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41614077},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48bddea7f874; sha256 9db47529fb468615e31258cacb96079d0a4638cd647ea88db90bd6a0cea1f626},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614077. Agents can read the archived copy with the MCP tool read_document.